Concepedia

Author

Simona Giovannelli

University of Modena and Reggio Emilia

Also Known As

S Giovannelli, S. Giovannelli, Simona Giovannelli

31

Publications

468

Citations

10

H-Index

15

Concepts

All Affiliations

University of Modena and Reggio EmiliaUniversity of PisaAzienda Ospedaliera Universitaria PisanaGlaxoSmithKline (United Kingdom)Ospedale di Livorno
SG

About

Simona Giovannelli is an author at University of Modena and Reggio Emilia specializing in breast cancer, oncology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

143

2

Surgical Oncology

3

3

129

3

Pathology

2

2

108

4

Pharmacology

2

2

35

5

Obstetrics

1

1

14

Simona Giovannelli

×

9

Publications

419

Citations

9

H-Index

YearCitations

Comparison of HER-2 and Hormone Receptor Expression in Primary Breast Cancers and Asynchronous Paired Metastases: Impact on Patient Management

Valentina Guarneri, Simona Giovannelli, Guido Ficarra,

The Oncologist

2008

152

Renal Safety and Efficacy of i.v. Bisphosphonates in Patients with Skeletal Metastases Treated for up to 10 Years

Valentina Guarneri, Sara Donati, Massimiliano Nicolini,

The Oncologist

2005

87

A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy

Valentina Guarneri, Federico Piacentini, Guido Ficarra,

Annals of Oncology

2009

78

Preoperative Chemotherapy plus Lapatinib or Trastuzumab or Both in HER2-Positive Operable Breast Cancer (CHERLOB Trial)

Valentina Guarneri, Antonio Frassoldati, Federico Piacentini,

Clinical Breast Cancer

2008

30

Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancer

Valentina Guarneri, Antonio Frassoldati, Guido Ficarra,

Breast Cancer Research and Treatment

2007

21

Letrozole Versus Letrozole plus Lapatinib (GW572016) in Hormone-Sensitive, HER2-Negative Operable Breast Cancer: A Double-Blind, Randomized, Phase II Study with Biomarker Evaluation (EGF109077-LAP107692/LETLOB)

Antonio Frassoldati, Valentina Guarneri, Federico Piacentini,

Clinical Breast Cancer

2008

14

Predictive and Prognostic Role of P53 According to Tumor Phenotype in Breast Cancer Patients Treated with Preoperative Chemotherapy: A Single-Institution Analysis

Valentina Guarneri, Elena Barbieri, Federico Piacentini,

The International Journal of Biological Markers

2010

13

EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition

Virginia Rotella, Lorenzo Fornaro, Enrico Vasile,

Journal of Experimental & Clinical Cancer Research

2014

13

A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients

Luigi Coltelli, Giacomo Allegrini, Paola Orlandi,

npj Breast Cancer

2022

11

Page 1